🇺🇸 FDA
Patent

US 10172932

Ebola virus disease vaccine taking human replication deficient adenovirus as vector

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10172932 (Ebola virus disease vaccine taking human replication deficient adenovirus as vector) held by Institute of Biotechnology, Academy of Military Medical Sciences, China expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Institute of Biotechnology, Academy of Military Medical Sciences, China
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K39/12, A61P